Overview

Gender

male

Dr. Geary is Senior Vice President of Development at Isis Pharmaceuticals. He is responsible for preclinical and clinical development of antisense drugs. Since joining Isis in 1995, Dr. Geary has been involved in discovery and development including the regulatory submission of more than 20 investigational new drug applications to U.S. and other regulatory agencies. During his tenure at Isis, he has authored or coauthored 10 book chapters and more than 40 peer-reviewed manuscripts, which form a body of work that fully characterize the pharmacokinetics and metabolism of antisense drugs and the relationship of drug concentrations to activity and safety.

Prior to joining Isis, Dr. Geary was Senior Research Scientist and Group Leader for the bioanalytical and preclinical pharmacokinetics group in the Applied Chemistry Department at Southwest Research Institute. Dr. Geary received his Ph.D. in Biopharmaceutics from the University of Texas, College of Pharmacy, Austin, Texas and his B.S. in Biology from Texas A&M University, College Station, Texas.